Amplia Therapeutics Limited (ASX:ATX)
Australia
· Delayed Price · Currency is AUD 0.0540
+0.0030 (5.88%)
Apr 28, 2025, 4:10 PM AEST
Amplia Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is April - March.
Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 4.56 | 3.39 | 9.26 | 14.61 | 1.85 | 1.11 | Upgrade
|
| Cash & Short-Term Investments | 4.56 | 3.39 | 9.26 | 14.61 | 1.85 | 1.11 | Upgrade
|
| Cash Growth | -19.42% | -63.43% | -36.63% | 690.33% | 66.81% | -10.70% | Upgrade
|
| Other Receivables | 1.39 | 3.18 | 1.15 | 1.84 | 1 | 0.03 | Upgrade
|
| Receivables | 1.39 | 3.18 | 1.15 | 1.84 | 1 | 0.03 | Upgrade
|
| Prepaid Expenses | 0.11 | 0.07 | 0.04 | 0.03 | 0.05 | 0.02 | Upgrade
|
| Other Current Assets | 0.09 | 0.12 | 0.07 | 0.05 | 0.04 | 0.01 | Upgrade
|
| Total Current Assets | 6.15 | 6.75 | 10.51 | 16.53 | 2.94 | 1.18 | Upgrade
|
| Property, Plant & Equipment | 0.06 | 0.1 | 0.18 | 0.01 | 0.01 | 0 | Upgrade
|
| Other Intangible Assets | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.05 | 0.05 | - | - | - | Upgrade
|
| Total Assets | 14.2 | 14.85 | 18.68 | 24.48 | 10.88 | 9.12 | Upgrade
|
| Accounts Payable | 1.31 | 1.6 | 0.35 | 0.37 | 0.49 | 0.47 | Upgrade
|
| Accrued Expenses | - | - | - | - | - | 0.03 | Upgrade
|
| Short-Term Debt | - | 1.49 | 2.11 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.05 | 0.08 | 0.07 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.05 | 0.23 | 0.22 | 0.16 | 0.05 | 0.01 | Upgrade
|
| Total Current Liabilities | 1.41 | 3.4 | 2.75 | 0.53 | 0.54 | 0.51 | Upgrade
|
| Long-Term Debt | - | - | - | 2.1 | - | - | Upgrade
|
| Long-Term Leases | - | 0.01 | 0.09 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.01 | 0 | 0.01 | - | - | Upgrade
|
| Total Liabilities | 1.43 | 3.43 | 2.85 | 2.64 | 0.54 | 0.51 | Upgrade
|
| Common Stock | 155.63 | 151.53 | 151.53 | 151.51 | 136.55 | 132.9 | Upgrade
|
| Retained Earnings | -141.78 | -139.01 | -134.72 | -128.62 | -125.21 | -122.93 | Upgrade
|
| Comprehensive Income & Other | -1.07 | -1.1 | -0.97 | -1.04 | -1.01 | -1.37 | Upgrade
|
| Shareholders' Equity | 12.77 | 11.42 | 15.84 | 21.85 | 10.34 | 8.61 | Upgrade
|
| Total Liabilities & Equity | 14.2 | 14.85 | 18.68 | 24.48 | 10.88 | 9.12 | Upgrade
|
| Total Debt | 0.05 | 1.59 | 2.28 | 2.1 | - | - | Upgrade
|
| Net Cash (Debt) | 4.5 | 1.8 | 6.98 | 12.51 | 1.85 | 1.11 | Upgrade
|
| Net Cash Growth | 31.80% | -74.23% | -44.19% | 576.70% | 66.81% | -10.70% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.01 | 0.04 | 0.09 | 0.02 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 274.8 | 271.61 | 194.01 | 193.85 | 107.97 | 66.46 | Upgrade
|
| Total Common Shares Outstanding | 274.8 | 194.01 | 194.01 | 193.85 | 107.97 | 66.46 | Upgrade
|
| Working Capital | 4.74 | 3.35 | 7.76 | 16 | 2.4 | 0.67 | Upgrade
|
| Book Value Per Share | 0.05 | 0.06 | 0.08 | 0.11 | 0.10 | 0.13 | Upgrade
|
| Tangible Book Value | 4.84 | 3.48 | 7.9 | 13.91 | 2.4 | 0.67 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.02 | 0.04 | 0.07 | 0.02 | 0.01 | Upgrade
|
| Machinery | - | - | - | 0.02 | 0.01 | 0 | Upgrade
|
Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.